The AI Applications in Biopharma Summit, which took place last week in Boston, was buzzing with conversation, community and talk of partnerships.
Key biopharma stakeholders and data driven disruptors met in Boston this week to discuss the rapidly evolving role of AI in the biopharma industry. Here, we provide a glimpse of the busy 1.5 day event.
Speaker Niven Narain, Ph.D., Co-Founder, President and CEO of BERG summarized the key theme of the Summit in his morning session: “The elephant in the room is, who is really doing AI the right way and what is the validation point?”
Niven R. Narain, Ph.D., Co-Founder, President & CEO, BERG
The conversations started at the Summit are already continuing in various forms post-event. Summit Chairman, Harry Glorikian, produced a special edition podcast series featuring Summit speakers as part of his MoneyBall Medicine podcast. The series will be available on the website in the next few weeks.
Kimberly Alba Mc Cord and Tom Davenport
Opportunities and Challenges of Using AI in Unlocking the ADME Tox Obstacles in Drug Development